Diagnostic vs. Preventive Cardiac AI: A Billion Dollar Distinction
People buying “cardiac AI” are often comparing apples to oranges, and it’s causing real confusion for clinical evaluators…
Cardiac AI: From Snapshot BP to Continuous Cardiac Intelligence
For anyone managing blood pressure, the familiar routine is a cuff-based reading at the doctor’s office, a single…
De-Risking Cardiac AI: The Due Diligence Checklist for Investors
ThoughtThe proliferation of artificial intelligence in cardiovascular medicine presents both far-reaching potential and a complex evaluative challenge for…
AI Stethoscopes: Unlocking a Billion-Dollar Heart Health Market
The stethoscope is an icon, but let’s be honest, auscultation has its limits. Even for a seasoned clinician,…
FDA-Cleared Cardiac AI: What Investors MUST Know
The cardiac AI monitoring market is set to explode, projected to jump from $2.2 billion in 2026 to…
Cardiac AI: Peer Review vs. Vendor Projection for Investors
In the world of cardiovascular AI, vendors love to make big promises about health outcomes and cost savings.…
Cardiac AI: Decoding “Advisory Forum” Claims for Investors
Cardiac AI is completely changing diagnostics and patient management, but that means clinical evaluators and procurement teams have…
Zio Watch: AI’s Path to a Billion Dollar Afib Market
The idea of getting real medical data from a watch has been around forever, a holy grail for…
Cardiac AI’s Form Factor Frontier: De-Risking Your Investment
The cardiovascular AI diagnostics field is exploding, throwing a lot of new tech at clinicians, buyers, and investors.…
The Silent Epidemic: Why AFib Stays Hidden Until Stroke
Atrial fibrillation (AFib) is the most common arrhythmia we deal with, and it’s a total paradox. It dramatically…